BIOA
Financials
- Market Capitalization 1.01 B
- Employee 62
- Founded 2015
- CEO N/A
- Website www.bioagelabs.com
- Headquarter Delaware, United States
- FIGI BBG00HBTB0M9
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2450 |  CRON Cronos Group Inc. - Common Share | 2.75 USD | 0.00% | 0.00% | +4.56% | +36.14% | 1.03 B USD | ||
| 2451 |  ETON Eton Pharmaceuticals, Inc. - Common Stock | 37.51 USD | +0.46% | +0.97% | +16.20% | +159.41% | 1.03 B USD | ||
| 2483 |  PCRX Pacira BioSciences, Inc. - Common Stock | 25.01 USD | -2.08% | -3.10% | +9.12% | +14.57% | 984.09 M USD | ||
| 2594 |  AMPH Amphastar Pharmaceuticals, Inc. - Common Stock | 18.81 USD | -2.49% | -4.71% | -5.52% | -22.85% | 829.39 M USD |
Frequently asked questions about BioAge Labs, Inc. - Common Stock
What is the BioAge Labs, Inc. - Common Stock stock price today?
The current price of BioAge Labs, Inc. - Common Stock (BIOA) is 22.78. Over the past 24 hours, the stock has changed by +4.54%. Follow the BIOA chart for real-time price dynamics.
What is the stock ticker of BioAge Labs, Inc. - Common Stock?
BioAge Labs, Inc. - Common Stock trades under the ticker BIOA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioAge Labs, Inc. - Common Stock stock going up?
BIOA has changed by -6.41% over the last week, +14.82% over the last month, and +199.74% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BioAge Labs, Inc. - Common Stock net income for the last quarter?
BioAge Labs, Inc. - Common Stock reported net income of -22.25 M for the last quarter. The previous quarter showed -25.94 M, which means net income changed by +14.22%.
How many employees does BioAge Labs, Inc. - Common Stock have?
As of the latest available data, BioAge Labs, Inc. - Common Stock has 62 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioAge Labs, Inc. - Common Stock EBITDA?
BioAge Labs, Inc. - Common Stock EBITDA is -25.62 M, and its EBITDA margin is -924.17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioAge Labs, Inc. - Common Stock stock?
You can buy BioAge Labs, Inc. - Common Stock (BIOA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioAge Labs, Inc. - Common Stock stock?
Investing in BioAge Labs, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BIOA chart and related analysis on metatrader.com as part of your research.